[4-(2-morpholin-4-ylethoxy)phenyl]acetic acid, 250mg

For-Met-OH, 98%, 5g

2-(3-Cyanophenoxy)acetamide, 95%, 1g

4-Bromo-2-fluoro-5-methylphenylisothiocyanate, 95.0%, 1g

1-Methyl-4-phenylpyridinium iodide, 95%, 100mg

1-Naphthhydrazide, 98.0%, 10g

4-Acetyl-3-fluorophenylboronic acid, 95.0%, 10g

2-Methylbutane, min. 99%, for synthesis, 2.5 L, glass packaging

1-(Difluoromethyl)-4-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-pyrazole, 97.0%, 5g

3-Aminobenzenesulfonic Acid>99.0%(T)25g

8-chloro-11-piperidin-4-ylidene-6,11-dihydro-5H-benzo[5,6]cyclohepta[1,2-b]pyridine, 99.00%, 100g

4-CHLORO-7-(TRIFLUOROMETHOXY)QUINAZOLINE, 95.0%, 250mg

4-nitro-1,2-dihydropyridin-2-one, 95%, 250mg